"alpha-2-Antiplasmin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A member of the serpin superfamily found in plasma that inhibits the lysis of fibrin clots which are induced by plasminogen activator. It is a glycoprotein, molecular weight approximately 70,000 that migrates in the alpha 2 region in immunoelectrophoresis. It is the principal plasmin inactivator in blood, rapidly forming a very stable complex with plasmin.
Descriptor ID |
D000979
|
MeSH Number(s) |
D12.644.861.050 D12.776.124.790.106.090 D12.776.377.715.085.090 D12.776.395.080 D12.776.872.050
|
Concept/Terms |
alpha-2-Antiplasmin- alpha-2-Antiplasmin
- Serpin F2
- alpha-2 Antiplasmin
- alpha 2 Antiplasmin
- alpha 2-Plasmin Inhibitor
- alpha 2 Plasmin Inhibitor
- alpha(2)-Plasmin Inhibitor
|
Below are MeSH descriptors whose meaning is more general than "alpha-2-Antiplasmin".
Below are MeSH descriptors whose meaning is more specific than "alpha-2-Antiplasmin".
This graph shows the total number of publications written about "alpha-2-Antiplasmin" by people in this website by year, and whether "alpha-2-Antiplasmin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "alpha-2-Antiplasmin" by people in Profiles.
-
Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes. Shock. 2022 01 01; 57(1):95-105.
-
Characterization of fibrin/fibrinogen degradation products reagents and their utility in critical care patients with enhanced fibrinolysis. Int J Lab Hematol. 2021 Aug; 43(4):813-820.
-
Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study. Thromb Res. 2019 01; 173:20-26.
-
Proteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarction. Blood. 2011 Jun 16; 117(24):6694-701.